Executive Summary .Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large "unmet need" in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and neurodegenerative diseases. The company’s proprietary and unique technology overcomes the major barriers to transplantation by a novel strategy utilizing patented micro-encapsulation technology, enabling a transplantable, cell-based therapy that avoids detection and rejection by the immune system.
Develop improved treatments specifically for diabetes and other chronic diseases using a novel type of therapeutic: implanted cells shielded by proprietary biomaterials from immune attack and the foreign body response (fibrosis) and inflammation.
Apply Altucell’s cell engineering and delivery system-based platform to re-program and control dynamic protein delivery for the long-term treatment of debilitating diseases.
Altucell's product portfolio is still in the development stage, and that any claims made about the product's safety or efficacy are based on early-stage research and may not be representative of final results. The product is not currently available for sale or distribution, and that there is no guarantee that it will receive FDA approval in the future. Given the company's FDA pre-IND readiness status.
Safe Harbor - forward looking statements
This Presentation includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward looking statements include estimated financial information. Such forward looking statements with respect to revenues, earnings, performance, strategies, prospects and other aspects of the businesses of Altucell after completion of the proposed business combination are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from expectations expressed or implied by such forward looking statements.
Copyright © 2018 ALTUCELL - All Rights Reserved
2070 Deer Park Ave.
Deer Park, New York 11729